Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas

Horm Metab Res. 1991 Sep;23(9):407-9. doi: 10.1055/s-2007-1003714.

Abstract

The effects of glucagon-like peptide 1 (7-36) amide [GLP-1 (7-36) amide] and glucagon on the release of islet amyloid polypeptide (IAPP), or amylin, from the isolated perfused rat pancreas were studied. In the presence of 5.6 mM glucose, GLP-1 (7-36) amide and glucagon stimulated the release of amylin from the perfused pancreas. The infusion of GLP-1 (7-36) amide at a concentration of 10(-9) M elicited a biphasic release of amylin similar to that of insulin. The cumulative output of amylin induced by 10(-9)M GLP-1 (7-36) amide was significantly higher than that by 10(-9)M glucagon (p less than 0.01). The amylin/insulin molar ratios induced by GLP-1 (7-36) amide and glucagon were about 1% and did not differ significantly. These findings suggest that GLP-1 (7-36) amide and glucagon stimulate the release of amylin from the pancreas and that the concomitant secretion of amylin and insulin might contribute to glucose homeostasis.

MeSH terms

  • Amyloid / metabolism*
  • Animals
  • Dose-Response Relationship, Drug
  • Glucagon / pharmacology*
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptides
  • Glucose / pharmacology
  • Homeostasis / drug effects
  • Homeostasis / physiology
  • Insulin / metabolism
  • Islet Amyloid Polypeptide
  • Male
  • Pancreas / metabolism*
  • Pancreas / physiology
  • Peptide Fragments / pharmacology*
  • Peptides / pharmacology*
  • Perfusion
  • Radioimmunoassay
  • Rats
  • Rats, Inbred Strains

Substances

  • Amyloid
  • Insulin
  • Islet Amyloid Polypeptide
  • Peptide Fragments
  • Peptides
  • glucagon-like peptide 1 (7-36)
  • Glucagon-Like Peptides
  • Glucagon-Like Peptide 1
  • Glucagon
  • Glucose